1α,25-dihydroxyvitamin D3 displays divergent growth effects in both normal and malignant cells

Steroids

Volumn 66, Issue 3-5, 2001, Pages 433-440

  Rashid, Samantha F ^a   Mountford, Joanne C ^a   Gombart, Adrian F ^b   Campbell, Moray J ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer cells; cyp24; Proliferation; Vitamin D3

Indexed keywords

1,24,25 TRIHYDROXYCOLECALCIFEROL; 1,25 DIHYDROXY 24 OXOCOLECALCIFEROL; ANTISENSE OLIGONUCLEOTIDE; CALCITRIOL; CALCITRIOL DERIVATIVE; CALCITRIOL RECEPTOR; CYTOCHROME P450 ISOENZYME; KETOCONAZOLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NORTHERN BLOTTING; OXIDATION; PROMYELOCYTE; SIGNAL TRANSDUCTION; VITAMIN D METABOLISM; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; METABOLISM; MYELOID LEUKEMIA; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY;

MINK CELL FOCUS-FORMING VIRUS;

BREAST NEOPLASMS; CALCITRIOL; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKEMIA, MYELOID; OXIDATION-REDUCTION; RECEPTORS, CALCITRIOL; TUMOR CELLS, CULTURED;

EID: 0035342702     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00203-8     Document Type: Conference Paper

References (36)

1. 3 and malignant melanoma; the presence of receptors and inhibition of cell growth in culture
2. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells
3. 3 analogues; A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines
4. Transcriptional activation of the Cdk inhibitor p21 by vitamin D leads to the induced differentiation of the myelomonocytic cell line U-937
5. 3 on proliferation and vitamin D receptor expression of rat growth cartilage cells
6. 3 on osteoclast formation in fetal mouse metatarsal organ cultures
7. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks
8. Effects of calcitriol on proliferation and differentiation of human fetal jejunum
9. 3; dependence on cell culture conditions
10. Induction of c-fos during myelomonocytic differentiation and macrophage proliferation
11. Bone and haematopoietic defects in mice lacking c-fos
12. 3 induction in myeloid leukemic cells
13. 3 in HL-60 cells
14. Height depends on month of birth
15. Plasma concentrations of vitamin D metabolites in puberty; effect of sexual maturation and implications for growth
16. Vitamin D (soltriol), light, and reproduction
17. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning
18. 3 analogues in breast cancer cells
19. Expression of 1,25-dihydroxyvitamin D3 receptor in breast carcinoma
20. Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer
21. Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL); Structural similarities with a new family of oncoproteins
22. Estrogen receptor mutations in breast cancer
23. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
24. 3 analog 1α,25-Dihydroxy-16-ene Vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells
25. 3 analogs and their 24-oxo metabolites display equally potent inhibitionof proliferation against a variety of cancer cell types but do not have the same molecular effects
26. 3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation
27. Estrone potentiates myeloid cell differentiation; a role for 17β-hydroxysteroid dehydrogenase in modulating hemopoiesis
28. Divergent molecular phenotypes of KG1 and KG1a myeloid cell lines
29. Membrane differentiation in human myeloid cells; expression of unique profiles of cell surface glycoproteins in myeloid leukemic cell lines blocked at different stages of differentiation and maturation
30. 3 receptor in bone, lung and other cancers
31. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines
32. 3 in seven human prostatic carcinoma cell lines
33. 3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
34. 3 are mediated exclusively through the genomic signaling pathway